Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel.
Bassol S, Alvarado A, Celis C, Cravioto MC, Peralta O, Montaño R, Novelli J, Albornoz H, Kesseru E, Soares A, Petracco A, Isaia B, Mendes J, Bahamondes L, de Melo NR, Reyes-Marquez R, Albrecht G. Bassol S, et al. Among authors: reyes marquez r. Contraception. 2000 Sep;62(3):131-5. doi: 10.1016/s0010-7824(00)00153-0. Contraception. 2000. PMID: 11124360 Clinical Trial.
A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American women.
Bassol S, Alvarado G, Arreola RG, Celis-Gonzalez C, Peña EP, Flores JG, Ahued JR, Ricalde RL, Lopez CR, Prieto G, Gurucharri C, Heredia MG, Ortiz OC, Percossi G, Figueroa Casas PR, Botto E, Tozzini RI, Botti G, Nuñez de Pierro A, Fernandez M, Lastreto E, Nañez M, Carneiro de Oliveira H, Diogenes Holanda Yazlle ME, Silva J, Salazar G, Gomez J, Penagos G, Cifuentes R, Torres LA, Reyes-Marquez R, Albrecht G. Bassol S, et al. Among authors: reyes marquez r. Contraception. 2003 May;67(5):367-72. doi: 10.1016/s0010-7824(02)00483-3. Contraception. 2003. PMID: 12742559
Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
Bassol S, Cravioto MC, Durand M, Bailon R, Carranza S, Fugarolas J, Gaona R, Parada LM, Celis C, Santoyo S, Garza-Flores J, Vazquez L, Lopez C, Gurucharri C, Novelli J, Carneiro de Oliveira H, Mendez J, de Andrade ME, de Mello NR, de Melo K, Chada E, Yassle ME, Castañeda A, Gomez P, Arboleda C, Trujillo L, Bucheli R, Hidalgo I, Olavide R, Parejarios J, Succar J, Reyes-Marquez R, Albrecht G. Bassol S, et al. Among authors: reyes marquez r. Contraception. 2000 May;61(5):309-16. doi: 10.1016/s0010-7824(00)00109-8. Contraception. 2000. PMID: 10906501 Clinical Trial.
The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
Bassol S, Carranza-Lira S, Celis-Gonzalez C, Santoyo S, Murillo A, Martinez N, Santos J, Llaca V, de la Loza FR, Zarain J, da Fonseca AM, Camargos AF, Baracat EC, da Sá MF, Bayo J, Adaro L, Gurucharri C, Murga M, Siseles N, Sayegh F, Tempone A, Tempone LM, Tozzini RI, Boccanera R, Naranjo C, Sanchez F, Gomez G, Blanco S, Reyes-Marquez R, Albrecht G, Rios PC. Bassol S, et al. Among authors: reyes marquez r. Maturitas. 2005 Mar 14;50(3):189-95. doi: 10.1016/j.maturitas.2004.05.014. Maturitas. 2005. PMID: 15734600 Clinical Trial.